IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.320
+0.080 (6.45%)
At close: Jun 6, 2025, 4:00 PM
1.320
0.00 (0.00%)
After-hours: Jun 6, 2025, 4:04 PM EDT

IGM Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
793634857289522,818
Upgrade
Market Cap Growth
-87.88%-25.13%-33.39%-23.49%-66.22%141.87%
Upgrade
Enterprise Value
-311901392877222,651
Upgrade
Last Close Price
1.246.118.3117.0129.3388.29
Upgrade
PS Ratio
28.11135.62227.82681.46--
Upgrade
PB Ratio
106.697.542.392.543.897.38
Upgrade
P/TBV Ratio
111.107.542.392.543.897.38
Upgrade
EV/Sales Ratio
-71.0765.47268.87--
Upgrade
Debt / Equity Ratio
62.980.940.200.140.120.03
Upgrade
Asset Turnover
0.010.010.010.00--
Upgrade
Quick Ratio
5.434.907.979.578.2621.25
Upgrade
Current Ratio
5.715.148.189.818.6721.65
Upgrade
Return on Equity (ROE)
-245.59%-155.76%-100.48%-83.09%-52.71%-26.16%
Upgrade
Return on Assets (ROA)
-36.78%-35.23%-34.91%-35.11%-29.24%-15.54%
Upgrade
Return on Capital (ROIC)
-86.87%-72.02%-57.16%-47.33%-30.95%-16.04%
Upgrade
Earnings Yield
-256.45%-53.89%-50.78%-30.35%-17.35%-2.89%
Upgrade
FCF Yield
-188.91%-43.72%-42.17%-2.20%-14.52%-3.03%
Upgrade
Buyback Yield / Dilution
-8.10%-15.68%-25.92%-24.09%-8.88%-241.82%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q